Modulation of gene expression by combination therapy

Details for Australian Patent Application No. 2004200032 (hide)

International Classifications

Event Publications

22 January 2004 Complete Application Filed

29 January 2004 Application Open to Public Inspection

Published as AU-B-2004200032

5 May 2005 Application Accepted

Published as AU-B-2004200032

1 September 2005 Standard Patent Sealed

1 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Examination has been requested or report issued for this patent. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

6 July 2006 Corrigenda

Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2004 Under the name Methylgene, Inc, Application No. 2004200032, correct the code to code to read 14.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.